LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Oral Bacteria Found in Cerebral Emboli of Stroke Patients

By LabMedica International staff writers
Posted on 05 Jun 2019
Print article
Image: The Abi Prism 7900 HT sequence detection system (Photo courtesy of Applied Biosystems).
Image: The Abi Prism 7900 HT sequence detection system (Photo courtesy of Applied Biosystems).
In addition to traditional causative factors, such as hypertension, hypercholesterolemia, diabetes mellitus, smoking, and obesity, bacterial inflammation has been suggested to contribute directly or indirectly to the development of the atherosclerosis and atherothrombotic events.

Chronic infections have been reported to be risk factors for both coronary heart disease and ischemic stroke. DNA of oral bacteria, mainly from the viridans streptococci group, has been detected in coronary thrombus aspirates of myocardial infarction and cerebral aneurysms. Cerebral artery thrombosis causes 87 % of strokes. Most thrombi originate in carotid artery stenoses from where they travel to block cerebral circulation.

Scientists from the University of Tampere (Tampere, Finland) analyzed thrombus aspirates, which neurointerventional radiologists removed from 75 stroke patients (69% men; mean age, 67 years), as part of emergency treatment. Bacterial DNA was extracted from samples using a commercially available QIAamp DNA Mini Kit.

Universal bacterial primers and probe24 were determined with RNaseP. The presence of Streptococcus species, mainly the Streptococcus mitis group, belonging to viridans streptococci as well as Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans in samples were determined using a quantitative polymerase chain reaction (qPCR) with specific primers and probes. The qPCR assays were performed using specific TaqMan allele hybridization with the AbiPrism 7900 HT Sequence Detection System.

The team reported that bacterial DNA was detected in 63 (84%) of aspired thrombi, and 12 (16%) of samples were considered bacterial DNA negative. DNA of Streptococcus species, mainly the S. mitis group, was found in 59 (79%) of samples. The median relative amount of Streptococcus species DNA was more than 5‐fold higher compared with the control blood samples from the same patients. All thrombi were negative for both P. gingivalis and A. actinomycetemcomitans.

The authors conclude that they had found DNA of Streptococcus species, mainly the S. mitis group, belonging to viridans streptococci, in most aspirated thrombi of the patients with Acute ischemic stroke (AIS). This suggests that viridans streptococci may have a role in the cause of cerebrovascular disease. Regular dental care should be emphasized in the primary prevention of AIS. The study was published on June 4, 2019, in the Journal of American Heart Association.

Related Links:
University of Tampere

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.